See more : Yunnan Aluminium Co., Ltd. (000807.SZ) Income Statement Analysis – Financial Results
Complete financial analysis of Ossen Innovation Co., Ltd. (OSN) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Ossen Innovation Co., Ltd., a leading company in the Steel industry within the Basic Materials sector.
You may be interested
- SBI (7729.TWO) Income Statement Analysis – Financial Results
- Argo Group US, Inc. 6.5% SR NTS 42 (ARGD) Income Statement Analysis – Financial Results
- Austin Engineering Limited (ANG.AX) Income Statement Analysis – Financial Results
- Astral Foods Limited (ARL.JO) Income Statement Analysis – Financial Results
- Arbe Robotics Ltd. (ARBEW) Income Statement Analysis – Financial Results
Ossen Innovation Co., Ltd. (OSN)
About Ossen Innovation Co., Ltd.
Ossen Innovation Co., Ltd. manufactures coated steel materials. The company is headquartered in Shanghai, Shanghai and currently employs 209 full-time employees. The firm manufactures and sells an array of plain surface prestressed steel materials, and rare earth coated and zinc coated prestressed steel materials. The firm's materials are used in the construction of bridges, highways and other infrastructure projects in the People's Republic of China and internationally. Its facilities are located in Maanshan City, Anhui Province and in Jiujiang City, Jiangxi Province, in the People's Republic of China. Its pre-stressed steel materials are categorized as plain surface products and coated products. Its products are marketed under the Ossen brand name both domestically and internationally. The firm's plain surface products include its uncoated plain surfaced and stabilized products. Its coated pre-stressed products included zinc coated PC products and rare earth coated PC products.
| Metric | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 138.58M | 138.90M | 136.10M | 132.38M | 117.03M | 117.91M | 123.57M | 113.89M | 122.40M | 118.62M | 117.45M | 101.09M | 82.74M |
| Cost of Revenue | 114.86M | 116.54M | 115.59M | 117.72M | 100.93M | 102.20M | 110.25M | 102.35M | 111.61M | 96.59M | 92.89M | 87.66M | 70.53M |
| Gross Profit | 23.72M | 22.36M | 20.52M | 14.65M | 16.10M | 15.71M | 13.32M | 11.54M | 10.79M | 22.03M | 24.56M | 13.43M | 12.21M |
| Gross Profit Ratio | 17.12% | 16.10% | 15.08% | 11.07% | 13.75% | 13.32% | 10.78% | 10.13% | 8.81% | 18.57% | 20.91% | 13.28% | 14.76% |
| Research & Development | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| General & Administrative | 6.96M | 6.16M | 5.26M | 6.00M | 6.38M | 4.48M | 6.34M | 3.49M | 3.95M | 2.75M | 1.20M | 1.14M | 1.32M |
| Selling & Marketing | 380.95K | 357.43K | 327.37K | 598.83K | 734.16K | 986.38K | 772.38K | 625.50K | 917.07K | 1.22M | 660.93K | 0.00 | 0.00 |
| SG&A | 7.34M | 6.51M | 5.59M | 6.60M | 7.11M | 5.46M | 7.11M | 4.11M | 4.87M | 3.96M | 1.86M | 1.14M | 1.32M |
| Other Expenses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 503.72K | 4.33M |
| Operating Expenses | 7.34M | 6.51M | 5.59M | 6.60M | 7.11M | 5.46M | 7.11M | 4.11M | 4.87M | 3.96M | 1.86M | 1.65M | 5.64M |
| Cost & Expenses | 122.19M | 123.05M | 121.18M | 124.32M | 108.04M | 107.66M | 117.36M | 106.46M | 116.48M | 100.55M | 94.76M | 89.31M | 76.18M |
| Interest Income | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Interest Expense | 2.86M | 2.38M | 1.62M | 1.61M | 2.83M | 2.82M | 2.40M | 2.70M | 3.56M | 3.48M | 2.44M | 1.50M | 1.89M |
| Depreciation & Amortization | 493.48K | 606.05K | 641.65K | 796.57K | 883.76K | 1.42M | 1.53M | 1.56M | 1.60M | 2.01M | 1.84M | 1.46M | 1.56M |
| EBITDA | 16.00M | 15.61M | 14.77M | 8.44M | 9.46M | 11.32M | 8.37M | 9.12M | 8.10M | 19.17M | 21.79M | 11.71M | 7.69M |
| EBITDA Ratio | 11.55% | 11.24% | 10.85% | 6.38% | 8.08% | 9.60% | 6.77% | 8.01% | 6.61% | 16.17% | 18.55% | 11.58% | 9.30% |
| Operating Income | 15.51M | 15.01M | 14.13M | 7.65M | 8.58M | 9.90M | 6.84M | 7.56M | 6.49M | 17.17M | 19.95M | 10.25M | 6.14M |
| Operating Income Ratio | 11.19% | 10.80% | 10.38% | 5.78% | 7.33% | 8.40% | 5.53% | 6.64% | 5.31% | 14.47% | 16.99% | 10.14% | 7.42% |
| Total Other Income/Expenses | -1.91M | -1.24M | -615.96K | -1.06M | -2.33M | -2.11M | -2.12M | -2.27M | -3.22M | -1.97M | 459.97K | 217.96K | -1.08M |
| Income Before Tax | 13.60M | 13.76M | 13.51M | 6.59M | 6.25M | 7.79M | 4.71M | 5.29M | 3.27M | 15.19M | 20.41M | 10.47M | 5.06M |
| Income Before Tax Ratio | 9.81% | 9.91% | 9.93% | 4.98% | 5.34% | 6.61% | 3.82% | 4.64% | 2.67% | 12.81% | 17.38% | 10.35% | 6.11% |
| Income Tax Expense | 1.57M | 1.53M | 2.13M | 691.56K | 926.05K | 1.18M | 578.73K | 1.22M | 557.43K | 2.14M | 2.87M | 740.05K | 291.52K |
| Net Income | 12.03M | 12.23M | 11.38M | 5.90M | 5.32M | 6.61M | 4.14M | 4.07M | 2.72M | 13.05M | 17.55M | 9.73M | 4.76M |
| Net Income Ratio | 8.68% | 8.80% | 8.36% | 4.46% | 4.55% | 5.61% | 3.35% | 3.57% | 2.22% | 11.01% | 14.94% | 9.62% | 5.76% |
| EPS | 1.82 | 1.85 | 1.73 | 0.89 | 0.81 | 1.00 | 0.62 | 0.61 | 0.41 | 1.96 | 3.47 | 1.95 | 0.95 |
| EPS Diluted | 1.82 | 1.85 | 1.73 | 0.89 | 0.81 | 1.00 | 0.62 | 0.61 | 0.41 | 1.96 | 3.47 | 1.95 | 0.95 |
| Weighted Avg Shares Out | 6.60M | 6.60M | 6.60M | 6.60M | 6.60M | 6.62M | 6.63M | 6.63M | 6.65M | 6.67M | 5.05M | 5.00M | 5.00M |
| Weighted Avg Shares Out (Dil) | 6.60M | 6.60M | 6.60M | 6.60M | 6.60M | 6.62M | 6.63M | 6.63M | 6.65M | 6.67M | 5.05M | 5.00M | 5.00M |
Aldeyra Therapeutics Selected to Present at the Disruptive Innovations Symposium during the OSN New York Retina 2024 Meeting
LEXINGTON, Mass.--(BUSINESS WIRE)--Aldeyra Therapeutics, Inc. (Nasdaq: ALDX) (Aldeyra), a biotechnology company devoted to discovering and developing innovative therapies designed to treat immune-mediated and metabolic diseases, today announced that Tomasz Stryjewski, M.D., Chief Medical Advisor - Retina, will present at the...
OSN+ partners with castLabs to enhance content protection with cutting-edge multi-DRM technology, DRMtoday
BERLIN and DUBAI, UAE, Sept. 10, 2024 /PRNewswire/ -- castLabs , a global pioneer in premium digital video technology, is thrilled to announce that OSN+ , the MENA region's leading premium streaming service, has chosen the company's cloud digital rights management...
Yintai obtains third and final PRC Approval
VANCOUVER, British Columbia, May 31, 2024 (GLOBE NEWSWIRE) -- Osino Resources Corp. (TSX:OSI.V) (NSX:OSN) (FSE:RSR1) ("Osino" or the "Company") today announced that, in connection with the previously announced statutory plan of arrangement under Business Corporations Act (British Columbia), pursuant to...
Osino obtains Final Court Order approving Plan of Arrangement and Yintai obtains NDRC Approval
VANCOUVER, British Columbia, May 15, 2024 (GLOBE NEWSWIRE) -- Osino Resources Corp. (TSX:OSI.V) (NSX:OSN) (FSE:RSR1) ("Osino" or the "Company") today announced that (i) it obtained on May 2, 2024 a final order from the Supreme Court of British Columbia approving...
Ossen Innovation Announces Completion of Merger
SHANGHAI, Sept. 9, 2021 /PRNewswire/ -- Ossen Innovation Co., Ltd.
Ossen Innovation Announces Unaudited Financial Results for the Six Months Ended June 30, 2021
SHANGHAI, Aug. 18, 2021 /PRNewswire/ -- Ossen Innovation Co., Ltd. ("Ossen Innovation" or the "Company") (Nasdaq: OSN), a China-based manufacturer of an array of plain surface, rare earth and zinc coated pre-stressed steel materials, today announced its unaudited financial results for the six months...
Ossen Innovation Could Offer +15% Return On Long-Awaited Take-Private Deal
Ossen Innovation Could Offer +15% Return On Long-Awaited Take-Private Deal
Ossen Innovation to Hold Extraordinary General Meeting of Shareholders
SHANGHAI, Aug. 5, 2021 /PRNewswire/ – Ossen Innovation Co., Ltd. (the "Company") (Nasdaq: OSN), a China-based manufacturer of an array of plain surface, rare earth and zinc coated pre-stressed steel materials, today announced it has called an extraordinary general meeting...
Ossen Innovation Enters into Amendment No. 1 to Merger Agreement for Going Private Transaction
SHANGHAI, June 16, 2021 /PRNewswire/ -- Ossen Innovation Co., Ltd. (the "Company") (Nasdaq: OSN), a China-based manufacturer of an array of plain surface, rare earth and zinc coated pre-stressed steel materials, today announced that it has entered into an Amendment...
Ossen Innovation Announces Full Year 2020 Financial Results
SHANGHAI, May 18, 2021 /PRNewswire/ -- Ossen Innovation Co., Ltd. ("Ossen Innovation" or the "Company") (Nasdaq: OSN), a China-based manufacturer of an array of plain surface, rare earth and zinc coated pre-stressed steel materials, today announced its financial results for...
Source: https://incomestatements.info
Category: Stock Reports